Decoding the diagnostic and therapeutic potential of microbiota using pan-body pan-disease microbiomics.

ABSTRACT: The human microbiome emerges as a promising reservoir for diagnostic markers and therapeutics. Since host-associated microbiomes at various body sites differ and diseases do not occur in isolation, a comprehensive analysis strategy highlighting the full potential of microbiomes should include diverse specimen types and various diseases. To ensure robust data quality and comparability across specimen types and diseases, we employ standardized protocols to generate sequencing data from 1931 prospectively collected specimens, including from saliva, plaque, skin, throat, eye, and stool, with an average sequencing depth of 5.3 gigabases. Collected from 515 patients, these samples yield an average of 3.7 metagenomes per patient. Our results suggest significant microbial variations across disease

SUBMITTER: Schmartz GP 

PROVIDER: S-EPMC11427559 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature